Literature DB >> 6273649

Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.

A H Fensom, P F Benson, A R Grant, L Jacobs.   

Abstract

The identification of female carriers of Fabry's disease is important for genetic counselling since prenatal diagnosis of affected fetuses is possible. The activities of either total alpha-galactosidase or alpha-galactosidase A in cultured fibroblasts were similar in Fabry carriers and controls and cannot therefore be used for carrier detection. Better discrimination between carriers and controls was found when total alpha-galactosidase activity was expressed as a ratio to beta-galactosidase activity, but overlap still occurred. However, there was complete discrimination between the ratio of alpha-galactosidase A to beta-galactosidase in cultured fibroblasts from five carriers of Fabry's disease and either 11 controls, seven hemizygote affected males or two of their female relatives.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6273649     DOI: 10.1007/bf01805555

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  Genetic heterogeneity of alpha-galactosidase in fabry's disease.

Authors:  G Romeo; B Childs; B R. Migeon
Journal:  FEBS Lett       Date:  1972-10-15       Impact factor: 4.124

Review 2.  Diagnosis of inherited enzymatic deficiencies with tears: Fabry disease.

Authors:  M A Del Monte; D L Johnson; E Cotlier; R J Desnick
Journal:  Birth Defects Orig Artic Ser       Date:  1976

3.  Angiokeratoma corporis diffusum. A clinical study of eight affected families.

Authors:  D WISE; H J WALLACE; E H JELLINEK
Journal:  Q J Med       Date:  1962-04

4.  Anderson-Fabry disease: rapid detection of carriers by hair bulb analysis.

Authors:  A Ejiofor; D Robinson; D Wise; M Hamers; J M Tager
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

5.  Fibroblast phosphodiesterase deficiency in Niemann-Pick disease.

Authors:  A H Fensom; P F Benson; A W Babarik; A R Grant; L Jacobs
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

6.  Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.

Authors:  R J Desnick; K Y Allen; S J Desnick; M K Raman; R W Bernlohr; W Krivit
Journal:  J Lab Clin Med       Date:  1973-02

7.  Fabry's disease: evidence for a physically altered -galactosidase.

Authors:  M W Ho; S Beutler; L Tennant; J S O'Brien
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

8.  Fabry's disease: absence of an -galactosidase isozyme.

Authors:  S Wood; H L Nadler
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

9.  Fabry's disease: antenatal detection.

Authors:  R O Brady; B W Uhlendorf; C B Jacobson
Journal:  Science       Date:  1971-04-09       Impact factor: 47.728

10.  Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles.

Authors:  M W Spence; A L Goldbloom; J K Burgess; D D'entremont; B A Ripley; K L Weldon
Journal:  J Med Genet       Date:  1977-04       Impact factor: 6.318

View more
  1 in total

1.  Complementation studies in Niemann-Pick disease type C indicate the existence of a second group.

Authors:  S J Steinberg; C P Ward; A H Fensom
Journal:  J Med Genet       Date:  1994-04       Impact factor: 6.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.